These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33536571)

  • 21. Proteins recruited to exosomes by tau overexpression implicate novel cellular mechanisms linking tau secretion with Alzheimer's disease.
    Saman S; Lee NC; Inoyo I; Jin J; Li Z; Doyle T; McKee AC; Hall GF
    J Alzheimers Dis; 2014; 40 Suppl 1(Suppl 1):S47-70. PubMed ID: 24718102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons.
    Amadoro G; Corsetti V; Florenzano F; Atlante A; Ciotti MT; Mongiardi MP; Bussani R; Nicolin V; Nori SL; Campanella M; Calissano P
    Neurobiol Dis; 2014 Feb; 62():489-507. PubMed ID: 24411077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
    Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
    J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabidiol Inhibits Tau Aggregation In Vitro.
    Alali S; Riazi G; Ashrafi-Kooshk MR; Meknatkhah S; Ahmadian S; Hooshyari Ardakani M; Hosseinkhani B
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of voluntary treadmill exercise and caloric restriction on tau pathogenesis in a mouse model of Alzheimer's disease-like tau pathology fed with Western diet.
    Gratuze M; Julien J; Morin F; Marette A; Planel E
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):452-461. PubMed ID: 28779908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory mechanisms of tau protein fibrillation under the conditions of liquid-liquid phase separation.
    Boyko S; Surewicz K; Surewicz WK
    Proc Natl Acad Sci U S A; 2020 Dec; 117(50):31882-31890. PubMed ID: 33262278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondria: the common upstream driver of amyloid-β and tau pathology in Alzheimer's disease.
    Silva DF; Esteves AR; Oliveira CR; Cardoso SM
    Curr Alzheimer Res; 2011 Aug; 8(5):563-72. PubMed ID: 21244356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial dysfunction, mitophagy, and role of dynamin-related protein 1 in Alzheimer's disease.
    Medala VK; Gollapelli B; Dewanjee S; Ogunmokun G; Kandimalla R; Vallamkondu J
    J Neurosci Res; 2021 Apr; 99(4):1120-1135. PubMed ID: 33465841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophagy and Tau Protein.
    Hamano T; Enomoto S; Shirafuji N; Ikawa M; Yamamura O; Yen SH; Nakamoto Y
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the potential role of rab5 protein in endo-lysosomal impairment in Alzheimer's disease.
    Behl T; Kaur D; Sehgal A; Singh S; Makeen HA; Albratty M; Abdellatif AAH; Dachani SR; Bungau S
    Biomed Pharmacother; 2022 Apr; 148():112773. PubMed ID: 35245734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevating the Levels of Calcium Ions Exacerbate Alzheimer's Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau.
    Guan PP; Cao LL; Wang P
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's disease risk modifier genes do not affect tau aggregate uptake, seeding or maintenance in cell models.
    Kolay S; Diamond MI
    FEBS Open Bio; 2020 Sep; 10(9):1912-1920. PubMed ID: 32649026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of action deconvolution of the small-molecule pathological tau aggregation inhibitor Anle138b.
    Hosseini-Gerami L; Ficulle E; Humphryes-Kirilov N; Airey DC; Scherschel J; Kananathan S; Eastwood BJ; Bose S; Collier DA; Laing E; Evans D; Broughton H; Bender A
    Alzheimers Res Ther; 2023 Mar; 15(1):52. PubMed ID: 36918909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinal Degeneration and Alzheimer's Disease: An Evolving Link.
    Ashok A; Singh N; Chaudhary S; Bellamkonda V; Kritikos AE; Wise AS; Rana N; McDonald D; Ayyagari R
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ginkgo biloba Extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons.
    Qin Y; Zhang Y; Tomic I; Hao W; Menger MD; Liu C; Fassbender K; Liu Y
    J Alzheimers Dis; 2018; 65(1):243-263. PubMed ID: 30010136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurogenetic contributions to amyloid beta and tau spreading in the human cortex.
    Sepulcre J; Grothe MJ; d'Oleire Uquillas F; Ortiz-Terán L; Diez I; Yang HS; Jacobs HIL; Hanseeuw BJ; Li Q; El-Fakhri G; Sperling RA; Johnson KA
    Nat Med; 2018 Dec; 24(12):1910-1918. PubMed ID: 30374196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide CRISPR screen identifies protein pathways modulating tau protein levels in neurons.
    Sanchez CG; Acker CM; Gray A; Varadarajan M; Song C; Cochran NR; Paula S; Lindeman A; An S; McAllister G; Alford J; Reece-Hoyes J; Russ C; Craig L; Capre K; Doherty C; Hoffman GR; Luchansky SJ; Polydoro M; Dolmetsch R; Elwood F
    Commun Biol; 2021 Jun; 4(1):736. PubMed ID: 34127790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMPK: Potential Therapeutic Target for Alzheimer's Disease.
    Yang L; Jiang Y; Shi L; Zhong D; Li Y; Li J; Jin R
    Curr Protein Pept Sci; 2020; 21(1):66-77. PubMed ID: 31424367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caspase-cleaved Tau-D(421) is colocalized with the immunophilin FKBP52 in the autophagy-endolysosomal system of Alzheimer's disease neurons.
    Meduri G; Guillemeau K; Dounane O; Sazdovitch V; Duyckaerts C; Chambraud B; Baulieu EE; Giustiniani J
    Neurobiol Aging; 2016 Oct; 46():124-37. PubMed ID: 27479154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.